OrthoPediatrics (KIDS) Expected to Announce Earnings on Thursday

OrthoPediatrics (NASDAQ:KIDS) is expected to release its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect OrthoPediatrics to post earnings of ($0.29) per share and revenue of $61.2720 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 26, 2026 at 4:30 PM ET.

OrthoPediatrics Stock Up 0.2%

KIDS opened at $17.09 on Thursday. The company has a market cap of $428.62 million, a PE ratio of -8.76 and a beta of 1.12. OrthoPediatrics has a twelve month low of $15.28 and a twelve month high of $26.40. The company has a 50-day moving average price of $17.71 and a 200 day moving average price of $18.25. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28.

Analyst Ratings Changes

A number of equities analysts have commented on KIDS shares. BTIG Research reissued a “buy” rating and set a $23.00 target price on shares of OrthoPediatrics in a report on Wednesday, October 29th. Needham & Company LLC dropped their price target on OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating for the company in a research report on Wednesday, October 29th. Wall Street Zen upgraded OrthoPediatrics from a “sell” rating to a “hold” rating in a report on Saturday, January 17th. TD Cowen raised shares of OrthoPediatrics to a “strong-buy” rating in a research note on Tuesday, January 27th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, OrthoPediatrics currently has a consensus rating of “Moderate Buy” and an average price target of $23.89.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds have recently modified their holdings of the company. Russell Investments Group Ltd. grew its stake in shares of OrthoPediatrics by 433.1% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after buying an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC purchased a new stake in shares of OrthoPediatrics in the 3rd quarter valued at approximately $54,000. BNP Paribas Financial Markets boosted its position in shares of OrthoPediatrics by 60.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after purchasing an additional 1,235 shares during the period. Finally, State of Wyoming grew its stake in shares of OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock valued at $121,000 after buying an additional 4,467 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.